Experimental Hematology
Volume 36, Issue 5 , Pages 609-623 , May 2008

Rapid platelet turnover in WASP(−) mice correlates with increased ex vivo phagocytosis of opsonized WASP(−) platelets

  • Amanda Prislovsky

      Affiliations

    • Department of Pathology and Laboratory Medicine, Memphis Veterans Administration Medical Center, Memphis, Tenn., USA
    • ,
  • Bindumadhav Marathe

      Affiliations

    • Department of Pathology and Laboratory Medicine, University of Tennessee Health Sciences Center, Memphis, Tenn., USA
    • ,
  • Amira Hosni

      Affiliations

    • Department of Pathology and Laboratory Medicine, Memphis Veterans Administration Medical Center, Memphis, Tenn., USA
    • Department of Chemistry, Faculty of Science, Fayoum University, Fayoum, Egypt
    • ,
  • Alyssa L. Bolen

      Affiliations

    • Department of Physiology, University of Tennessee Health Sciences Center, Memphis, Tenn., USA
    • ,
  • Falk Nimmerjahn

      Affiliations

    • Laboratory for Experimental Immunology and Immunotherapy, Nikolaus-Fiebiger-Centre, Erlangen, Germany
    • ,
  • Carl W. Jackson

      Affiliations

    • Division of Experimental Hematology, Department of Hematology/Oncology, St. Jude Children's Research Hospital, Memphis, Tenn., USA
    • ,
  • Darryl Weiman

      Affiliations

    • Department of Surgery, Memphis Veterans Administration Medical Center, Memphis, Tenn., USA
    • ,
  • Ted S. Strom

      Affiliations

    • Department of Pathology and Laboratory Medicine, Memphis Veterans Administration Medical Center, Memphis, Tenn., USA
    • Department of Pathology and Laboratory Medicine, University of Tennessee Health Sciences Center, Memphis, Tenn., USA
    • Corresponding Author InformationOffprint requests to: Ted S. Strom, M.D., Ph.D., Department of Pathology and Laboratory Medicine, Memphis VA Medical Center, 1030 Jefferson Avenue, Memphis, TN 38104

Received 21 August 2007 ,Revised 4 December 2007 ,Accepted 31 December 2007.

References 

  1. Wiskott A. Familiarer, angeborener morbus werlhofii. Monatsschrift fur kinderheilkunde. 1936;68:212–216
  2. Aldrich R, Steinberg AG, Campbell DC. Pedigree demonstrating a sex-linked recessive condition characterized by draining ears, eczematoid dermatitis and bloody diarrhea. Pediatrics. 1954;13:133–139
  3. She HY, Rockow S, Tang J, et al. Wiskott-Aldrich syndrome protein is associated with the adapter protein Grb2 and the epidermal growth factor receptor in living cells. Mol Biol Cell. 1997;8:1709–1721
  4. Le Page Y, Demay F, Salbert G. A neural-specific splicing event generates an active form of the Wiskott-Aldrich syndrome protein. EMBO Rep. 2004;5:895–900
  5. Badour K, Zhang J, Siminovitch KA. Involvement of the Wiskott-Aldrich syndrome protein and other actin regulatory adaptors in T cell activation. Semin Immunol. 2004;16:395–407
  6. Burns S, Cory GO, Vainchenker W, Thrasher AJ. Mechanisms of WASp-mediated hematologic and immunologic disease. Blood. 2004;104:3454–3462
  7. Sullivan KE, Mullen CA, Blaese RM, Winkelstein JA. A multiinstitutional survey of the Wiskott-Aldrich syndrome. J Pediatr. 1994;125:876–885
  8. Jin Y, Mazza C, Christie JR, et al. Mutations of the Wiskott-Aldrich Syndrome Protein (WASP): hotspots, effect on transcription, and translation and phenotype/genotype correlation. Blood. 2004;104:4010–4019
  9. Notarangelo LD, Mazza C, Giliani S, et al. Missense mutations of the WASP gene cause intermittent X-linked thrombocytopenia. Blood. 2002;99:2268–2269
  10. Mullen C, Anderson KD, Blaese RM. Splenectomy and/or bone marrow transplantation in the management of the Wiskott-Aldrich syndrome: long-term followup of 52 cases. Blood. 1993;82:2961–2966
  11. Schurman SH, Candotti F. Autoimmunity in Wiskott-Aldrich syndrome. Curr Opin Rheumatol. 2003;15:446–453
  12. Baldini MG. Nature of the platelet defect in the Wiskott-Aldrich syndrome. Ann N Y Acad Sci. 1972;201:437–444
  13. Grottum KA, Hovig T, Holmsen H, Abrahamsen AF, Jeremic M, Seip M. Wiskott-Aldrich syndrome: qualitative platelet defects and short platelet survival. Br J Haematol. 1969;17:373–388
  14. Murphy S, Oski FA, Naiman JL, Lusch CJ, Goldberg S, Gardner FH. Platelet size and kinetics in hereditary and acquired thrombocytopenia. N Engl J Med. 1972;286:499–504
  15. Ochs HD, Slichter SJ, Harker LA, Von Behrens WE, Clark RA, Wedgwood RJ. The Wiskott-Aldrich syndrome: studies of lymphocytes, granulocytes, and platelets. Blood. 1980;55:243–252
  16. Kajiwara M, Nonoyama S, Eguchi M, et al. WASP is involved in proliferation and differentiation of human haemopoietic progenitors in vitro. Br J Haematol. 1999;107:254–262
  17. Sabri S, Foudi A, Boukour S, et al. Deficiency in the Wiskott-Aldrich protein induces premature proplatelet formation and platelet production in the bone marrow compartment. Blood. 2006;108:134–140
  18. Haddad E, Cramer E, Riviere C, et al. The thrombocytopenia of Wiskott Aldrich syndrome is not related to a defect in proplatelet formation. Blood. 1999;94:509–518
  19. Shcherbina A, Rosen FS, Remold-O'Donnell E. Pathological events in platelets of Wiskott-Aldrich syndrome patients. Br J Haematol. 1999;106:875–883
  20. Gross BS, Wilde JI, Quek L, Chapel H, Nelson DL, Watson SP. Regulation and function of WASp in platelets by the collagen receptor, glycoprotein VI. Blood. 1999;94:4166–4176
  21. Rengan R, Ochs HD, Sweet LI, et al. Actin cytoskeletal function is spared, but apoptosis is increased, in WAS patient hematopoietic cells. Blood. 2000;95:1283–1292
  22. Falet H, Hoffmeister KM, Neujahr R, Hartwig JH. Normal Arp2/3 complex activation in platelets lacking WASp. Blood. 2002;100:2113–2122
  23. Semple JW, Siminovitch KA, Mody M, et al. Flow cytometric analysis of platelets from children with the Wiskott-Aldrich syndrome reveals defects in platelet development, activation and structure. Br J Haematol. 1997;97:747–754
  24. Snapper SB, Rosen FS, Mizoguchi E, et al. Wiskott-Aldrich syndrome protein-deficient mice reveal a role for WASP in T but not B cell activation. Immunity. 1998;9:81–91
  25. Zhang J, Shehabeldin A, da Cruz LA, et al. Antigen receptor-induced activation and cytoskeletal rearrangement are impaired in Wiskott-Aldrich syndrome protein-deficient lymphocytes. J Exp Med. 1999;190:1329–1342
  26. Andreansky S, Liu CH, Turner SJ, et al. WASP- mice Exhibit Defective Immune Responses to Influenza A Virus, Streptococcus pneumoniae, and Mycobacterium bovis BCG. Exp Hematol. 2005;33:443–451
  27. Mizutani H, Engelman RW, Kurata Y, Ikehara S, Good RA. Development and characterization of monoclonal antiplatelet autoantibodies from autoimmune thrombocytopenic purpura-prone (NZW x BXSB)F1 mice. Blood. 1993;82:837–844
  28. Kaneko Y, Nimmerjahn F, Ravetch JV. Anti-inflammatory activity of immunoglobulin G resulting from Fc sialylation. Science. 2006;313:670–673
  29. Manning KL, McDonald TP. C3H mice have larger spleens, lower platelet counts, and shorter platelet lifespans than C57BL mice: an animal model for the study of hypersplenism. Exp Hematol. 1997;25:1019–1024
  30. Arnold JT, Daw NC, Stenberg PE, Jayawardene D, Srivastava DK, Jackson CW. A single injection of pegylated murine megakaryocyte growth and development factor (MGDF) into mice is sufficient to produce a profound stimulation of megakaryocyte frequency, size, and ploidization. Blood. 1997;89:823–833
  31. Alugupalli KR, Michelson AD, Barnard MR, Leong JM. Serial determinations of platelet counts in mice by flow cytometry. Thromb Haemost. 2001;86:668–671
  32. Olsson M, Bruhns P, Frazier WA, Ravetch JV, Oldenborg PA. Platelet homeostasis is regulated by platelet expression of CD47 under normal conditions and in passive immune thrombocytopenia. Blood. 2005;105:3577–3582
  33. Strom T, Turner SJ, Lang R, et al. Wiskott-Aldrich Syndrome (WAS) knockout mice can be phenotypically corrected by transplantation of syngeneic hematopoietic stem cells transduced with a WASP-expressing retroviral vector. Mol Ther. 2002;5:S23
  34. Ault KA, Rinder HM, Mitchell J, Carmody MB, Vary CP, Hillman RS. The significance of platelets with increased RNA content (reticulated platelets). A measure of the rate of thrombopoiesis. Am J Clin Pathol. 1992;98:637–646
  35. Strom TS, Li X, Cunningham JM, Nienhuis AW. Correction of the murine Wiskott-Aldrich syndrome phenotype by hematopoietic stem cell transplantation. Blood. 2002;99:4626–4628
  36. Harrison P, Horton A, Grant D, Briggs C, MacHin S. Immunoplatelet counting: a proposed new reference procedure. Br J Haematol. 2000;108:228–235
  37. Ault KA, Knowles C. In vivo biotinylation demonstrates that reticulated platelets are the youngest platelets in circulation. Exp Hematol. 1995;23:996–1001
  38. Berger G, Hartwell DW, Wagner DD. P-Selectin and platelet clearance. Blood. 1998;92:4446–4452
  39. Dale GL, Friese P, Hynes LA, Burstein SA. Demonstration that thiazole-orange-positive platelets in the dog are less than 24 hours old. Blood. 1995;85:1822–1825
  40. Robinson M, MacHin S, Mackie I, Harrison P. In vivo biotinylation studies: specificity of labelling of reticulated platelets by thiazole orange and mepacrine. Br J Haematol. 2000;108:859–864
  41. Schulze H, Korpal M, Hurov J, et al. Characterization of the megakaryocyte demarcation membrane system and its role in thrombopoiesis. Blood. 2006;107:3868–3875
  42. Adelman B, Carlson P, Handin RI. Evaluation of platelet surface antigens by fluorescence flow cytometry. Methods Enzymol. 1992;215:420–427
  43. Phillips DR, Jakabova M. Ca2+-dependent protease in human platelets. Specific cleavage of platelet polypeptides in the presence of added Ca2+. J Biol Chem. 1977;252:5602–5605
  44. Oyaizu N, Yasumizu R, Miyama-Inaba M, et al. (NZW x BXSB)F1 mouse. A new animal model of idiopathic thrombocytopenic purpura. J Exp Med. 1988;167:2017–2022
  45. Mizumoto Y, Fujimura Y, Nishikawa K, et al. Flow cytometric analysis of anti-platelet antibodies in patients with chronic idiopathic thrombocytopenic purpura (ITP) using acid-treated, formalin-fixed platelets. Am J Hematol. 1991;37:274–276
  46. Santoso S, Kiefel V, Mueller-Eckhardt C. Redistribution of platelet glycoproteins induced by allo- and autoantibodies. Thromb Haemost. 1987;58:866–871
  47. Santoso S, Zimmermann U, Neppert J, Mueller-Eckhardt C. Receptor patching and capping of platelet membranes induced by monoclonal antibodies. Blood. 1986;67:343–349
  48. Hanson SR, Slichter SJ. Platelet kinetics in patients with bone marrow hypoplasia: evidence for a fixed platelet requirement. Blood. 1985;66:1105–1109
  49. McMillan R. Antiplatelet antibodies in chronic adult immune thrombocytopenic purpura: assays and epitopes. J Pediatr Hematol Oncol. 2003;25(Suppl 1):S57–S61
  50. George JN. Platelet immunoglobulin G: its significance for the evaluation of thrombocytopenia and for understanding the origin of alpha-granule proteins. Blood. 1990;76:859–870
  51. Musaji A, Cormont F, Thirion G, Cambiaso CL, Coutelier JP. Exacerbation of autoantibody-mediated thrombocytopenic purpura by infection with mouse viruses. Blood. 2004;104:2102–2106
  52. Corash L, Shafer B, Blaese RM. Platelet-associated immunoglobulin, platelet size, and the effect of splenectomy in the Wiskott-Aldrich syndrome. Blood. 1985;65:1439–1443
  53. Kanegane H, Nomura K, Miyawaki T, et al. X-linked thrombocytopenia identified by flow cytometric demonstration of defective Wiskott-Aldrich syndrome protein in lymphocytes. Blood. 2000;95:1110–1111
  54. Litzman J, Jones A, Hann I, Chapel H, Strobel S, Morgan G. Intravenous immunoglobulin, splenectomy, and antibiotic prophylaxis in Wiskott-Aldrich syndrome. Arch Dis Child. 1996;75:436–439
  55. Oldenborg PA, Gresham HD, Chen Y, Izui S, Lindberg FP. Lethal autoimmune hemolytic anemia in CD47-deficient nonobese diabetic (NOD) mice. Blood. 2002;99:3500–3504
  56. Lorenzi R, Brickell PM, Katz DR, Kinnon C, Thrasher AJ. Wiskott-Aldrich syndrome protein is necessary for efficient IgG-mediated phagocytosis. Blood. 2000;95:2943–2946
  57. Tsuboi S, Meerloo J. Wiskott-Aldrich syndrome protein is a key regulator of the phagocytic cup formation in macrophages. J Biol Chem. 2007;282:34194–34203
  58. Leverrier Y, Lorenzi R, Blundell MP, et al. Cutting edge: the Wiskott-Aldrich syndrome protein is required for efficient phagocytosis of apoptotic cells. J Immunol. 2001;166:4831–4834
  59. Zhang H, Schaff UY, Green CE, et al. Impaired integrin-dependent function in Wiskott-Aldrich syndrome protein-deficient murine and human neutrophils. Immunity. 2006;25:285–295

PII: S0301-472X(08)00015-5

doi: 10.1016/j.exphem.2007.12.019

Experimental Hematology
Volume 36, Issue 5 , Pages 609-623 , May 2008

Article Tools

* Image Usage & Resolution